KAUST researchers have published a study in Nature Genetics detailing genomic analysis of wild rice relatives. The study examined nine tetraploid and two diploid wild relatives of rice, finding significant genetic diversity due to transposable elements. This diversity includes genes that confer resilience to heat, drought, and salinity. Why it matters: These findings can help improve rice yields, introduce rice cultivation to currently untenable regions, and protect rice crops against climate change, especially in the Middle East.
KAUST researchers, in collaboration with Spanish scientists, have released the Global Ocean Gene Catalog 1.0, the world's largest open-source catalog of marine microbes. The catalog, created using the KAUST Metagenomic Analysis Platform (KMAP), matches microbial class with gene function, geographic location, and habitat type, including 317 million unique gene clusters. The catalog analyzes 2102 ocean samples taken from different depths and locations around the world. Why it matters: This resource will enable researchers to investigate ocean ecosystems, track pollution impact, and explore biotechnology applications, potentially driving significant advances in fields like antibiotic discovery and plastic degradation.
KAUST researchers are analyzing the SARS-CoV-2 genome to identify potential targets for treatment and vaccine development. They are using the KAUST Metagenome Analysis Platform (KMAP) and the university's supercomputer to compare and analyze genomic data. The research focuses on identifying key genes for detection and treatment of COVID-19. Why it matters: This research contributes to the global effort to combat the pandemic and highlights KAUST's capabilities in genomic data analysis and computational bioscience.
Petar Stojanov from the Broad Institute of MIT and Harvard will give a talk on cancer data analysis, covering the fundamentals of cancer, the nature of large-scale data collected, and main analysis objectives. The talk will also address open questions in cancer data analysis and how machine learning and generative modeling can help. Stojanov's research focuses on applying machine learning to genomic analysis of cancer mutation and single-cell RNA sequencing data. Why it matters: Applying AI and machine learning to cancer research can lead to a better understanding of the disease and development of new therapies.